Search results
Navidea drops rheumatoid arthritis programme after failed Phase III trial
Pharmaceutical Technology· 11 hours agoIII study (NCT05246280), which enrolled 523 patients, aimed to confirm the ability of intravenous...
DK Shivakumar issues warning to party members on leadership row | Bengaluru News - Times of India
The Times of India· 5 days agoBENGALURU : DK Shivakumar, deputy CM and KPCC president, issued a stern warning Saturday, asking...
FDA Approves Skyrizi for Ulcerative Colitis
Verywell Health· 6 days agoThe FDA approves Skyrizi for the treatment of Ulcerative colitis. Here's what approval means and how the drug compares to other treatment options...
INmune Bio’s unique Alzheimer’s trial endpoint receives validation
Clinical Trials Arena· 6 days agoThe AD02 trial (NCT05318976), investigating INmune’s tumour necrosis factor (TNF) XPro, is using...
Coherus offloads Humira biosimilar Yusimry for $40m
Pharmaceutical Technology· 7 days agoThe US approval for these biosimilars is expected in 2026. Yusimry is a tumour necrosis factor (TNF) blocker and has been approved for nine indications –...
Kerala govt issues warning against amoebic meningoencephalitis: Know what it is - Times of India
The Times of India· 7 days agoDue to continued rain in Kerala, the health department has issued caution on amoebic...